Horst Sievert
Overview
Explore the profile of Horst Sievert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
435
Citations
10910
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions
Pancaldi E, Adamo M, Pagnesi M, Russo G, Alessandrini H, Andreas M, et al.
Int J Cardiol
. 2025 Mar;
:133137.
PMID: 40068787
Aims: To assess the association between right heart failure (RHF) and mortality in patients with severe tricuspid regurgitation (TR) undergoing transcatheter tricuspid valve intervention (TTVI), and to determine whether clinical...
2.
Piayda K, Bertog S, Sievert K, Sievert H, Shaburishvili T, Gogorishvili I, et al.
JACC Heart Fail
. 2025 Jan;
13(2):386-388.
PMID: 39818666
No abstract available.
3.
Schwammenthal E, Gogorishvili I, Sievert H, Fefer P, Pinto D
JACC Cardiovasc Interv
. 2024 Dec;
17(24):2851-2862.
PMID: 39722267
Background: The Magenta Elevate is a 9-F, self-expanding, catheter-mounted pump delivered sheathed through a commercially available 10-F femoral introducer over the wire to the left ventricle (LV), providing temporary hemodynamic...
4.
Rosenthal E, Qureshi S, Sivakumar K, Jones M, Yong S, Kabir S, et al.
Circulation
. 2024 Dec;
PMID: 39697167
Background: Covered stent correction for a sinus venosus atrial septal defect (SVASD) was first performed in 2009. This innovative approach was initially viewed as experimental and was reserved for highly...
5.
Tekieli L, Mazgaj M, Ruzsa Z, Janus B, Paluszek P, Sievert H, et al.
Postepy Kardiol Interwencyjnej
. 2024 Oct;
20(3):248-254.
PMID: 39464584
No abstract available.
6.
Zeijen V, Volz S, Zeller T, Mahfoud F, Kunz M, Kuck K, et al.
Clin Res Cardiol
. 2024 Oct;
PMID: 39441345
Background: Ultrasound renal sympathetic denervation (uRDN) reduces blood pressure (BP) in the absence and presence of antihypertensive treatment at 2 months. Beyond 3 years, there is a lack of follow-up...
7.
Russo G, Pedicino D, Pires Marafon D, Adamo M, Alessandrini H, Andreas M, et al.
JACC Cardiovasc Interv
. 2024 Sep;
17(18):2170-2179.
PMID: 39322365
Background: Transcatheter tricuspid valve intervention (TTVI) has been increasingly adopted in recent years for the treatment of patients with tricuspid regurgitation (TR). However, no dedicated risk stratification has been established...
8.
Piayda K, Bertog S, Mbai M, Sharma A, Veulemans V, Sievert H
Cardiol Clin
. 2024 Sep;
42(4):537-545.
PMID: 39322344
Percutaneous PFO closure is a well-established medical procedure to mitigate paradoxic embolism and the future risk of stroke in a well-selected patient clientele. When it comes to procedural guidance during...
9.
Yu F, Dong X, Sun Y, Reddy V, Sievert H, Tang M
JACC Basic Transl Sci
. 2024 Sep;
9(8):971-981.
PMID: 39297134
In this study, we investigated the feasibility, safety, and efficiency of using a novel device system to perform percutaneous left atrial appendage occlusion concomitant with left atrial appendage electrical isolation...
10.
Cannata F, Sticchi A, Russo G, Stankowski K, Hahn R, Alessandrini H, et al.
Eur Heart J Cardiovasc Imaging
. 2024 Aug;
26(1):135-147.
PMID: 39189600
Aims: Transcatheter tricuspid valve interventions (TTVI) are increasingly used to treat patients with significant tricuspid regurgitation (TR). The evolution of concurrent mitral regurgitation (MR) severity after TTVI is currently unknown...